Cognitive and Mood Effects of a Soluble Mango Leaf Extract (Zynamite® S): A Randomized, Double-Blind, Placebo-Controlled, Crossover Replication Trial
Pharmaceuticals · 18.07.2026 · 19 (7) · 1112
DOI: 10.3390/ph19071112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 18.07.2026. Verfasst von Ana Beltrán-Arranz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nektium Pharma S.L., Las Mimosas 8, Agüimes, 35118 Las Palmas, Spain. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nektium Pharma S.L..
Abstract (Originalsprache)
Background/Objectives: Botanical nootropics are increasingly sought as natural alternatives to synthetic stimulants. Mangifera indica leaf extract, standardized to the polyphenol mangiferin, has shown promise in regulating brain activity and enhancing cognitive performance. This study aimed to replicate, in an independent cohort, the acute cognitive benefits of a soluble mango leaf extract (Zynamite® S) following a previous proof-of-concept trial.
Methods
In a double-blind, randomized, placebo-controlled crossover trial, 88 healthy young adults (aged 18–25) received either a single 100 mg dose of Zynamite® S or a matched placebo. Cognitive performance was assessed using the Trail Making Test (TMT), Digit Symbol Substitution Test (DSST), and Stroop Color-Word Test. Emotional states were assessed via the Profile of Mood States (POMS) at baseline, and then at 30 min, 3 h, and 5 h post-ingestion.
Results
Zynamite® S supplementation resulted in the replication of previous findings, with significant improvements in mental processing speed, attention, and cognitive flexibility (p < 0.05). Notably, this trial identified a rapid onset of action, with significant cognitive and mood improvements detectable as early on as 30 min post-dose and a sustained duration of the effect with benefits observed up to 5 h post-administration. Mood assessments confirmed an overall improvement in emotional balance (p < 0.05) by reducing tension, mental fatigue, and low mood during the completion of cognitive-demanding tasks.
Conclusions
These findings reproduce the acute benefits of Zynamite® S in a healthy young adult population, including a rapid onset of effects and a sustained improvement in cognitive performance and mood over a 5 h window.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nektium Pharma S.L., Las Mimosas 8, Agüimes, 35118 Las Palmas, Spain.
- Department of Health Sciences, Faculty of Health Sciences, University of Jaén, 23071 Jaén, Spain.
- Department of Organic Chemistry, Faculty of Sciences, University of Malaga, Campus de Teatinos s/n, 29071 Málaga, Spain.
- Department of Educational Sciences, Faculty of Social Sciences, University of Atlántico Medio, 35017 Las Palmas de Gran Canaria, Spain.
ORCID-Profile: Ana Beltrán-Arranz, Agustín Aibar-Almazán, David Fuentes-Ríos, Rubén Pérez-Machín, María Del Carmen Carcelén-Fraile, Laura López-Ríos, Yolanda Castellote-Caballero
Förderung
- Nektium Pharma S.L.
Zitieren
APA
Beltrán-Arranz, A., Aibar-Almazán, A., Fuentes-Ríos, D., Pérez-Machín, R., Carcelén-Fraile, M. D. C., López-Ríos, L., & Castellote-Caballero, Y. (2026). Cognitive and Mood Effects of a Soluble Mango Leaf Extract (Zynamite® S): A Randomized, Double-Blind, Placebo-Controlled, Crossover Replication Trial. Pharmaceuticals, 19(7), 1112. https://doi.org/10.3390/ph19071112
Vancouver
Beltrán-Arranz A, Aibar-Almazán A, Fuentes-Ríos D, Pérez-Machín R, Carcelén-Fraile MDC, López-Ríos L, et al. Cognitive and Mood Effects of a Soluble Mango Leaf Extract (Zynamite® S): A Randomized, Double-Blind, Placebo-Controlled, Crossover Replication Trial. Pharmaceuticals. 2026;19(7):1112. doi:10.3390/ph19071112
BibTeX
@article{BeltrnArranz2026,
author = {Beltrán-Arranz, Ana and Aibar-Almazán, Agustín and Fuentes-Ríos, David and Pérez-Machín, Rubén and Carcelén-Fraile, María Del Carmen and López-Ríos, Laura and Castellote-Caballero, Yolanda},
title = {Cognitive and Mood Effects of a Soluble Mango Leaf Extract (Zynamite® S): A Randomized, Double-Blind, Placebo-Controlled, Crossover Replication Trial},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {7},
pages = {1112},
doi = {10.3390/ph19071112}
}
EUVIMED